|
Featuring Tedeschi Trucks
Fireside Live, Honoring Mike Rawls,
CEO Xome Holdings LLC
The Samuel Waxman Cancer Research Foundation (SWCRF) is
excited to announce its 27th Annual Collaborating for A Cure
Gala, taking place on Thursday, November 21, 2024, at
Cipriani Wall Street in New York City. This year’s
star-studded event will feature a special musical
performance by Tedeschi Trucks Fireside Live with
a very special guest.
“We are thrilled to welcome back Tedeschi Trucks
Fireside Live. Their incredible talent and commitment
to giving back make them the perfect fit for our event,”
said Michael Nierenberg, chairman of the SWCRF Board of
Directors. “As we celebrate our 27th year, we remain
dedicated to funding world-class research that leads to
better treatments and, ultimately, cures for cancer once and
for all.”
Known as one of New York City’s most anticipated fundraising
events of the year, The Waxman gala brings together leaders
from business, fashion, philanthropy, and entertainment to
support groundbreaking cancer research. This year’s honoree
is Mike Rawls, chief executive officer at Xome Holdings LLC.
Rawls will receive the 2024 Distinguished Business Leader
Award for his steadfast commitment to supporting cancer
research.
The Samuel Waxman Cancer Research Foundation, founded in
1976, is committed to finding cures through its pioneering
"Institute Without Walls" program, which fosters
collaboration among leading scientists worldwide to
accelerate the pace of research and bring new treatments to
patients faster. Funds raised at the annual event directly
support the SWCRF mission to eradicate cancer through
innovative research aimed at developing less toxic, more
effective treatments.
About the Samuel Waxman Cancer Research
Foundation (SWCRF):
The Samuel Waxman Cancer Research Foundation is an
international organization dedicated to curing and
preventing cancer. The Foundation is a pioneer in cancer
research and its mission is to eradicate cancer by funding
cutting-edge research that identifies and corrects abnormal
gene function that causes cancer and develops minimally
toxic treatments for patients. Through the Foundation’s
collaborative group of world-class scientists, the Institute
Without Walls, investigators share information and tools to
speed the pace of cancer research. Since its inception in
1976, the Samuel Waxman Cancer Research Foundation has
awarded more than $120 million to support the work of more
than 200 researchers across the globe.
|